Six months worth of medication Basically were stockpiling it for you
Human studies: While researchers were concerned to find GLP-1 receptors on thyroid C-cells in rodents (thyroid C-cells produce a hormone that helps regulate calcium levels in blood), in human studies, the evidence linking GLP-1 agonists to increased thyroid cancer risk, including MTC, is lacking
Provincial Drug Plans and Diabetes-Only Coverage Ontarios Ontario Drug Benefit (ODB) program, British Columbias PharmaCare, Quebecs public prescription drug insurance plan, and other provincial programs do provide coverage for GLP-1 medications like Wegovy, but exclusively for Type 2 diabetes management, not for weight management
Semaglutide (Ozempic, Wegovy) is an FDA-approved GLP-1 receptor agonist for type 2 diabetes and chronic weight management, formulated exclusively for subcutaneous injection into fatty tissue beneath the skin
Mixed with 2.5 mL, that gives 2,000 mcg/mL